
Penumbra Market Cap | PEN
As of November 19, 2026 Penumbra has a market cap of $ 12.5 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.2 B | 10.4 B | 10.1 B | 9.9 B | 8.15 B | 10.2 B | 6.19 B | 4.88 B | 3.34 B | 2.16 B | 513 M | 13.6 M | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.2 B | 13.6 M | 6.59 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Electromed
ELMD
|
325 M | $ 23.59 | 1.99 % | $ 195 M | ||
|
Inogen
INGN
|
160 M | $ 5.58 | -1.85 % | $ 148 M | ||
|
Globus Medical
GMED
|
12.5 B | $ 70.5 | 0.73 % | $ 9.53 B | ||
|
Quanterix Corporation
QTRX
|
269 M | $ 2.07 | -27.62 % | $ 88.3 M | ||
|
IRadimed Corporation
IRMD
|
1.25 B | $ 82.34 | -1.33 % | $ 1.05 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
339 M | $ 0.26 | -8.45 % | $ 16.8 M | ||
|
ClearPoint Neuro
CLPT
|
316 M | $ 7.77 | -1.21 % | $ 220 M | ||
|
Accuray Incorporated
ARAY
|
31.9 M | $ 2.49 | 2.05 % | $ 305 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 56.98 | 2.9 % | $ 2.62 B | ||
|
IRIDEX Corporation
IRIX
|
16.6 M | $ 0.5 | -28.53 % | $ 8.47 M | ||
|
Cytosorbents Corporation
CTSO
|
34.8 M | $ 5.1 | 12.83 % | $ 317 M | ||
|
Sensus Healthcare
SRTS
|
72.3 M | $ 2.3 | 1.55 % | $ 37.6 M | ||
|
Stryker Corporation
SYK
|
147 B | $ 318.0 | 0.14 % | $ 122 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
945 M | $ 13.87 | 2.32 % | $ 1.06 B | ||
|
Tactile Systems Technology
TCMD
|
640 M | $ 26.45 | 1.54 % | $ 605 M | ||
|
Bruker Corporation
BRKR
|
5.58 B | $ 63.28 | 3.13 % | $ 9.61 B | ||
|
LivaNova PLC
LIVN
|
3.81 B | $ 94.44 | 2.74 % | $ 5.15 B | ||
|
Tandem Diabetes Care
TNDM
|
1.26 B | $ 16.97 | -0.53 % | $ 1.15 B | ||
|
Profound Medical Corp.
PROF
|
166 M | $ 6.87 | -2.97 % | $ 208 M | ||
|
LENSAR
LNSR
|
71.3 M | $ 4.91 | -0.07 % | $ 58.7 M | ||
|
Orthofix Medical
OFIX
|
491 M | $ 6.59 | -1.27 % | $ 261 M | ||
|
Pulmonx Corporation
LUNG
|
72.8 M | $ 2.69 | -1.83 % | $ 109 M | ||
|
InspireMD
NSPR
|
115 M | $ 0.68 | 4.58 % | $ 43.7 M | ||
|
InMode Ltd.
INMD
|
928 M | $ 12.87 | -0.43 % | $ 832 M | ||
|
OrthoPediatrics Corp.
KIDS
|
437 M | $ 31.67 | 0.81 % | $ 743 M | ||
|
Outset Medical
OM
|
52.5 M | $ 3.04 | -3.8 % | $ 46.2 M | ||
|
PAVmed
PAVM
|
5.81 M | $ 1.3 | -13.91 % | $ 872 K | ||
|
AVITA Medical
RCEL
|
104 M | $ 16.71 | 5.96 % | $ 466 M | ||
|
Sintx Technologies
SINT
|
6.91 M | $ 1.21 | -2.42 % | $ 3.36 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Beyond Air
XAIR
|
4.15 B | $ 1.84 | -8.46 % | $ 15.3 B | ||
|
Xtant Medical Holdings
XTNT
|
78.1 M | $ 0.21 | 3.74 % | $ 29.3 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Vivos Therapeutics
VVOS
|
15.1 M | $ 0.08 | -5.9 % | $ 822 K | ||
|
Varex Imaging Corporation
VREX
|
502 M | $ 18.14 | 0.19 % | $ 751 M | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 7.38 | -2.06 % | $ 997 M | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Inspire Medical Systems
INSP
|
1.76 B | $ 58.04 | -2.31 % | $ 1.7 B | ||
|
Integer Holdings Corporation
ITGR
|
2.98 B | $ 126.97 | -0.01 % | $ 4.41 B | ||
|
Avanos Medical
AVNS
|
628 M | $ 24.99 | - | $ 1.16 B | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
4.03 B | $ 1.62 | -0.92 % | $ 35.7 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
89.5 M | - | - | $ 140 M |